Hypertension in Pregnancy Linked to Severity of Menopausal Symptoms

Researchers sought to determine whether a relationship exists between hypertensive disorders of pregnancy and menopausal symptoms.

Fezolinetant Reduces Frequency, Severity of Vasomotor Symptoms in Menopause

The neurokinin 3 receptor antagonist fezolinetant reduces the frequency and severity of vasomotor symptoms in menopause.

Vasomotor Symptoms at Menopause Linked to Increased Risk for CVD Events

Frequent or persistent vasomotor symptoms during the menopause transition are associated with increased risk for later cardiovascular disease events.

Using a Risk Model to Identify Osteoporotic Fracture Risk in Postmenopausal Women

Researchers sought to assess the ability of the Fracture Risk Assessment Tool to discriminate between women who do and do not experience major osteoporotic fractures.

Higher Estradiol Dose Improves Metabolic Profile in Early But Not Late Postmenopausal Women

Higher estradiol doses had significant benefits for cardiovascular risk factors in early postmenopausal women, but these effects were attenuated in late postmenopausal women.

Discussing Postmenopausal Vulvovaginal Symptoms at a Well-Woman Visit

Researchers sought to determine patient and visit characteristics associated with the discussion of postmenopausal vulvovaginal symptoms at well-woman examinations.